Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"A little bit of masking tape and a lot of glitter": Perspectives of older LGBT+ Australians on navigating aged care.

Geriatric nursing (New York, N.Y.)·2026
Same author

Advancing emergency medicine across Asia: a roadmap for leadership, collaboration, and digital transformation.

International journal of emergency medicine·2026
Same author

Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease.

Current diabetes reports·2026
Same author

Application of Digital, Web-Based, and Online Strategies in Point of Care Ultrasound (POCUS) Training: A Scoping Review.

Health science reports·2026
Same author

'There's No Improvement. I'm Still Bedridden': Recovery After Hospital Admission for Low Back Pain and Alignment With Patient Expectations.

Musculoskeletal care·2026
Same author

The Topographical, Sensory, and Temporal Characteristics of Pain in Parkinson's Disease: A Cross-Sectional Survey.

Pain practice : the official journal of World Institute of Pain·2026

Related Experiment Videos

Cinnamon for diabetes mellitus.

Matthew J Leach1, Saravana Kumar

  • 1School of Nursing & Midwifery, University of South Australia, Adelaide, South Australia. Matthew.leach@unisa.edu.au.

The Cochrane Database of Systematic Reviews
|September 14, 2012
PubMed
Summary
This summary is machine-generated.

This systematic review found insufficient evidence to support cinnamon use for diabetes management. More high-quality trials are needed to confirm its effects on blood glucose and long-term health outcomes.

Related Experiment Videos

Area of Science:

  • Metabolic Disorders
  • Evidence-Based Medicine
  • Dietary Interventions

Background:

  • Diabetes mellitus is a chronic condition linked to severe health complications.
  • Effective glycaemic control is crucial for mitigating diabetes-related risks.
  • Cinnamon has shown potential in animal studies for improving glycaemic control.

Purpose of the Study:

  • To systematically review randomized controlled trials on cinnamon's effects in diabetic patients.
  • To evaluate cinnamon's impact on glycaemic control and related markers.

Main Methods:

  • Searched multiple databases up to January 2012 for relevant randomized controlled trials.
  • Included trials comparing oral cinnamon monopreparations to placebo or no treatment in type 1 or type 2 diabetes.
  • Two reviewers independently assessed trial quality, risk of bias, and extracted data.

Main Results:

  • Ten trials with 577 participants were analyzed; most had high or unclear risk of bias.
  • Cinnamon (mean 2g/day for 4-16 weeks) showed inconclusive effects on fasting blood glucose.
  • No significant differences in HbA1c, serum insulin, or postprandial glucose were observed.

Conclusions:

  • Current evidence is insufficient to recommend cinnamon for managing type 1 or type 2 diabetes.
  • Further rigorous trials are needed, focusing on methodological quality and comprehensive endpoints.
  • Future research should include health-related quality of life, complications, and costs.